VERZONI, ELENA
VERZONI, ELENA
Universita' degli Studi di MILANO
Biomarker-driven immunotherapy for precision medicine in prostate cancer
2022-01-01 A. Ottini, P. Sepe, T. Beninato, M. Claps, V. Guadalupi, E. Verzoni, P. Giannatempo, G. Baciarello, F. De Braud, G. Procopio
Butterfly and renal cell cancer : Out of chaos comes order
2014-09-01 G. Procopio, E. Verzoni, F. De Braud
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21)
2022-01-02 A. Mennitto, E. Zattarin, M. Di Maio, D. Bimbatti, U. De Giorgi, S. Buti, D. Santini, C. Casadei, M. Soraru, C. Messina, C. Mucciarini, G. Di Lorenzo, G. Roviello, C. Buttigliero, M. Stellato, P. Sepe, M. Claps, V. Guadalupi, A. Ottini, S. Pignata, F.G. De Braud, E. Verzoni, G. Procopio
Cabozantinib in the treatment of advanced renal cell carcinoma : Design, development, and potential place in the therapy
2016-01-01 P. Grassi, E. Verzoni, R. Ratta, A. Mennitto, F. de Braud, G. Procopio
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma
2015-06-01 E. Zanardi, E. Verzoni, P. Grassi, A. Necchi, P. Giannatempo, D. Raggi, F. De Braud, G. Procopio
Clinical impact of Pancreatic metastases from renal cell carcinoma : A multicenter retrospective analysis
2016-04-01 P. Grassi, L. Doucet, P. Giglione, V. Grünwald, B. Melichar, L. Galli, U. De Giorgi, R. Sabbatini, C. Ortega, M. Santoni, A. Bamias, E. Verzoni, L. Derosa, H. Studentova, M. Pacifici, J. Coppa, V. Mazzaferro, F. De Braud, C. Porta, B. Escudier, G. Procopio
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
2017-09-01 P. Grassi, E. Verzoni, R. Ratta, L. Porcu, M. Prisciandaro, A. Mennitto, G. Calareso, F. de Braud, G. Procopio
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma : a systematic review and meta-analysis of literature data
2015-04-01 R. Iacovelli, M. Santoni, E. Verzoni, P. Grassi, I. Testa, F. De Braud, S. Cascinu, G. Procopio
First line treatment of metastatic renal cell carcinoma : two standards with different toxicity profile
2014-01-01 R. Iacovelli, E. Verzoni, F. De Braud, G. Procopio
From biology to clinical experience : evolution in the knowledge of neuroendocrine tumours
2009-01-01 E. Bajetta, G. Procopio, S. Pusceddu, F. Pietrantonio, M. Milione, M. Maccauro, E. Verzoni, V. Guadalupi, M. Platania
Immunotherapy advances in uro-genital malignancies
2016-09-01 R. Ratta, R. Zappasodi, D. Raggi, P. Grassi, E. Verzoni, A. Necchi, M. Di Nicola, R. Salvioni, F. de Braud, G. Procopio
Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer : a systematic review and meta-analysis
2015-01-01 R. Iacovelli, C.N. Sternberg, C. Porta, E. Verzoni, F. de Braud, B. Escudier, G. Procopio
Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients
2021-06-20 D. Rinchai, E. Verzoni, V. Huber, A. Cova, P. Squarcina, L. De Cecco, F. de Braud, R. Ratta, M. Dugo, L. Lalli, V. Vallacchi, M. Rodolfo, J. Roelands, C. Castelli, D. Chaussabel, G. Procopio, D. Bedognetti, L. Rivoltini
Management of advanced genitourinary tumors
2012-01-01 F. Pietrantonio, P. Biondani, E. Verzoni, G. Procopio
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents
2017-02-01 P. Grassi, L. Doucet, P. Giglione, V. Grünwald, B. Melichar, L. Galli, U. De Giorgi, R. Sabbatini, C. Ortega, M. Santoni, A. Bamias, E. Verzoni, L. Derosa, H. Studentova, L. Porcu, F. De Braud, C. Porta, G. Procopio
Patient approach in advanced/metastatic renal cell carcinoma : focus on the elderly population and treatment-related toxicity
2013-11-01 E. Verzoni, F. de Braud, F. Fabiani, P. Grassi, I. Testa, G. Procopio
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors : implications for clinical practice, trial design, and molecular interrogation
2015-07-01 D. Raggi, L. Mariani, P. Giannatempo, S. Lo Vullo, D. Giardiello, N. Nicolai, L. Piva, D. Biasoni, M. Catanzaro, T. Torelli, S. Stagni, M. Maffezzini, G. Calareso, M. Magni, M. Di Nicola, E. Verzoni, P. Grassi, G. Procopio, F. De Braud, G. Pizzocaro, R. Salvioni, A. Necchi
Prognostic role of pancreatic metastases from renal cell carcinoma : Results from an Italian center
2013-12-01 P. Grassi, E. Verzoni, L. Mariani, F. De Braud, J. Coppa, V. Mazzaferro, G. Procopio
Rationale and protocol of RESORT, a randomized, open-label, multicenter phase II study to evaluate the efficacy of sorafenib in patients with advanced renal cell carcinoma after radical resection of the metastases
2014-01-01 G. Procopio, E. Verzoni, P. Biondani, P. Grassi, I. Testa, E. Garanzini, F. de Braud
Rationale and protocol of SOAP : A phase II study to evaluate the efficacy of Sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma
2014-12-01 R. Iacovelli, E. Verzoni, P. Grassi, A. Farcomeni, F. De Braud, G. Procopio